| SANTHERA N | 1.3300 / +2.31% |
News
- Santhera and ReveraGen Start Rolling NDA Submission to the FDA for Vamorolone for the Treatment of Duchenne Muscular Dystrophy
03/29/2022 / 07:00 - GlobeNewswire - Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference
03/15/2022 / 07:05 - GlobeNewswire - Santhera Completes Ordinary Capital Increase to Create Treasury Shares for Future Financing
03/15/2022 / 07:00 - GlobeNewswire - Santhera Announces Preliminary 2021 Financial Results and Increases Issued Share Capital to Create Treasury Shares for Future Financing
03/11/2022 / 07:00 - GlobeNewswire - Santhera Signs Gene Therapy Agreement with SEAL Therapeutics
02/28/2022 / 07:00 - GlobeNewswire - Santhera Completes Repayment of 2017/22 Convertible Bonds
02/18/2022 / 07:00 - GlobeNewswire - Idorsia announces financial results for 2021 – 2022 to be a transformative year – Sustainable profitability expected in 2025
02/08/2022 / 07:00 - GlobeNewswire - Santhera Enters into Exclusive License Agreement with Sperogenix for Vamorolone in Rare Diseases in the Greater China Region
01/04/2022 / 07:00 - GlobeNewswire - Santhera’s Shareholders Approve all Board Proposals at Today’s Extraordinary General Meeting
12/15/2021 / 13:17 - GlobeNewswire - Santhera to Host Investor Conference Call — Looking Ahead to 2022
12/06/2021 / 07:00 - GlobeNewswire - Santhera Provides Corporate Update and Calls Extraordinary General Meeting to Seek Approval for Further Financings
11/24/2021 / 07:00 - GlobeNewswire - Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completion of the VISION-DMD Study
11/23/2021 / 07:00 - GlobeNewswire - Santhera and ReveraGen Announce Successful FDA Pre-NDA Meeting for Vamorolone in Duchenne Muscular Dystrophy
11/17/2021 / 07:00 - GlobeNewswire - Santhera Appoints Stephanie Brown as President North America and Member of the Executive Management Team
11/04/2021 / 07:00 - GlobeNewswire - Santhera Announces First Half-Year 2021 Financial Results and Updates on Corporate Progress
10/15/2021 / 20:00 - GlobeNewswire
Real-time